Natural Capsules has informed that a meeting of the Board of Directors of the Company will be held on October 29, 2015, to consider and approve the unaudited financial results for the quarter ended September 30, 2015 and submit to auditor of the Company for limited review as per Clause 41 of the listing agreement, and to consider and analyze the current business activities of Supreem Pharmaceuticals Mysore.
The above information is a part of company’s filings submitted to BSE.